Merriman Wealth Management, LLC Mannkind Corp Transaction History

Merriman Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$3.14 - $6.14 $44,588 - $87,188	-14,200 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.79 - $4.04 $25,418 - $57,368	14,200 New	14,200 $45,000
Q1 2020 Apr 22, 2020	SELL	$0.84 - $1.76 $11,928 - $24,992	-14,200 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$1.14 - $1.49 $16,187 - $21,158	14,200 New	14,200 $18,000

244

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.76B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Merriman Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Merriman Wealth Management, LLC with notifications on news.